1521-60-4

Basic information

• Product Name: 3-Nitromesidine
• Synonyms: 3-Nitromesidine;2,4,6-Trimethyl-3-nitroaniline;Nitromesidine
• CAS NO: 1521-60-4
• Molecular Formula: C₉H₁₂N₂O₂
• Molecular Weight: 180.2
• Mol File: 1521-60-4.mol
• Article Data: 3

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 3-Nitromesidine(CAS DataBase Reference)
• NIST Chemistry Reference: 3-Nitromesidine(1521-60-4)
• EPA Substance Registry System: 3-Nitromesidine(1521-60-4)

Safety Data

• Hazardous Substances Data: 1521-60-4(Hazardous Substances Data)

Upstream product

• 7664-93-9 sulfuric acid 
• 88-05-1 2,4,6-trimethylaniline 
• 108-67-8 1,3,5-trimethyl-benzene 
• 5096-21-9 N-mesitylacetamide 
• 696621-31-5 acetic acid-(2,4,6-trimethyl-3-nitro-anilide) 
• 608-50-4 2,4-dinitromesitylene 

Downstream Products

• 392-61-0 1,3-difluoro-2,4,6-trimethylbenzene 
• 363-64-4 1,3,5-trimethyl-2,4,6-trifluorobenzene 
• 444-03-1 3-fluoro-2,4,6-trimethyl-aniline 
• 67396-82-1 3-chloro-2,4,6-trimethylaniline 
• 443-99-2 5-fluoro-2,4,6-trimethyl-m-phenylenediamine 
• 443-98-1 3,5-difluoro-2,4,6-trimethyl-aniline 
• 314-36-3 1-(3,5-difluoro-2,4,6-trimethyl-phenyl)-ethanone 
• 362-52-7 3,5-difluoro-2,4,6-trimethyl-benzonitrile 
• 602-95-9 3-fluoro-2,4,6-trimethyl-5-nitro-aniline 
• 314-37-4 1,3-difluoro-2,4,6-trimethyl-5-nitro-benzene 
• 602-91-5 2,2,2-trichloro-1-(3,5-difluoro-2,4,6-trimethyl-phenyl)-ethanone 
• 602-90-4 2,2,2-tribromo-1-(3,5-difluoro-2,4,6-trimethyl-phenyl)-ethanone 
• 436-60-2 1-fluoro-2,4,6-trimethyl-3,5-dinitro-benzene 
• 386-62-9 1,3,5-tris-dichloromethyl-2,4,6-trifluoro-benzene 

Relevant articles and documents

Enantiospecific Synthesis of Nepetalactones by One-Step Oxidative NHC Catalysis

An efficient oxidative NHC-catalyzed one-step transformation of (S)-or (R)-8-oxocitronellal to nepetalactone (NL) in enantio- A nd diastereomerically pure form has been developed. Several new and "easy to make" N-Mes-or N-Dipp-substituted 1,2,4-triazolium salts carrying nitroaromatic groups on N1 were synthesized and evaluated as precatalysts in combination with base and stoichiometric organic oxidant. Under optimized conditions, NLs are accessible in very good yields and diastereomerically pure under mild conditions. The oxidant used could be recovered and recycled under operationally simple conditions.

TETRAHYDROISOQUINOLINE COMPOUND AND MEDICINAL USE THEREOF

The present invention provide a tetrahydroisoquinoline compound having a superior ACAT-inhibitory activity and/or anti-oxidation action, particularly, novel compound represented by the formula (I) (wherein each symbol is as described in the specification) and a pharmaceutically acceptable salt thereof.